Claims for Patent: 7,001,602
✉ Email this page to a colleague
Summary for Patent: 7,001,602
| Title: | Use of botulinum toxin therapy for urinary incontinence and related disorders |
| Abstract: | The present invention relates to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. |
| Inventor(s): | Schmidt; Richard A. (Arvada, CO) |
| Assignee: | The Regents of the University of Colorado (Boulder, CO) |
| Application Number: | 10/685,995 |
| Patent Claims: | 1. A method for treating urinary incontinence in a patient, the method comprising the step of administering to a patient with urinary incontinence a botulinum toxin, thereby
treating the urinary incontinence.
2. The method of claim 1, wherein the patent is a human. 3. The method of claim 1, wherein the patient is a human female. 4. The method of claim 1, wherein the botulinum toxin is a botulinum toxin type A. 5. The method of claim 1, wherein the botulinum toxin is administered in a pharmaceutically acceptable formulation selected from the group consisting of: a liquid, a powder, a cream, an emulsion, a pill, a troche, a suppository, a suspension, and a solution. 6. The method of claim 1, wherein the botulinum toxin is administered in a pharmaceutically acceptable formulation selected from the group consisting of a cream, a suspension and an emulsion. 7. The method of claim 1, wherein the botulinum toxin is injected into the urinary tract or the bladder of the patient in a pharmaceutically acceptable formulation selected from the group consisting of: a liquid, an emulsion, a suspension, and a solution. 8. The method of claim 1, wherein the patient has urge incontinence. 9. The method of claim 1, wherein administration of the botulinum toxin results in increased bladder capacity in the patient. 10. The method of claim 1, wherein administration of the botulinum toxin results in reduced bladder spasticity in the patient. 11. A method for treating urinary incontinence in a human patient, the method comprising the step of administering to a human patient with urinary incontinence a botulinum toxin type A, thereby treating the urinary incontinence. 12. The method of claim 1, wherein the patient has incontinence resulting from traumatic injury. 13. The method of claim 1, wherein the patient has incontinence resulting from injury to the vertebrae. |
Details for Patent 7,001,602
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Abbvie Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | 7,001,602 | 2017-07-15 |
| Abbvie Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | 7,001,602 | 2017-07-15 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Showing 1 to 2 of 2 entries
International Patent Family for US Patent 7,001,602
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2005234633 | ⤷ Try for Free |
| Austria | E314085 | ⤷ Try for Free |
| Austria | E320815 | ⤷ Try for Free |
| Austria | E339220 | ⤷ Try for Free |
| Austria | E448792 | ⤷ Try for Free |
| Austria | E552006 | ⤷ Try for Free |
| >Country | >Patent Number | >Estimated Expiration |
Showing 1 to 6 of 6 entries
